CONX Financials Monday, July 14, 2014 10:38:54 PM
Post# of 5
Corgenix Medical Corp.
Period Ending Jun 30, 2013 Jun 30, 2012 Jun 30, 2011 Jun 30, 2010
Total Revenue 10,188 9,289 7,942 8,258
Cost of Revenue 5,624 5,355 4,012 4,031
Gross Profit 4,564 3,934 3,929 4,227
Operating Expenses
Research and Development 583 517 194 229
Sales, General and Admin. 3,684 3,886 3,385 3,669
Non-Recurring Items - 17 486 -
Other - - - -
Operating Income 296 (486) (136) 328
Income From Continuing Operations
Add'l Income/Expense Items 3 5 1 (21)
Earnings Before Interest and Tax 299 (481) (135) 307
Interest Expense 21 122 258 321
Earnings Before Tax 279 (604) (393) (14)
Income Tax - - - (16)
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations 279 (604) (393) (20)
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income 279 (604) (393) 2
Preferred Stock and Other Adjustments (3) (20) (21) (44)
Net Income Applicable to Common Shareholders 275 (623) (415) (41)